Protective effects of human iPS-derived retinal pigmented epithelial cells in comparison with human mesenchymal stromal cells and human neural stem cells on the degenerating retina in rd1 mice

Stem Cells

Volumn 33, Issue 5, 2015, Pages 1543-1553

  Sun, Jianan ^a,b   Mandai, Michiko ^a   Kamao, Hiroyuki ^a,c   Hashiguchi, Tomoyo ^a   Shikamura, Masayuki ^d   Kawamata, Shin ^d   Sugita, Sunao ^a   Takahashi, Masayo ^a  

^a RIKEN Center for Biosystems Dynamics Research   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

^d FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

Cell based therapy; Induced pluripotent stem cells; Pigment epithelium derived factor; Retinal degeneration; Retinal pigment epithelium cells; Transplantation

Indexed keywords

5' NUCLEOTIDASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; ENDOGLIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MICROTUBULE ASSOCIATED PROTEIN 2; NESTIN; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN; PROTEIN ZO1; RHODOPSIN; SOMATOMEDIN; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA2; TUJ1 PROTIEN; UNCLASSIFIED DRUG; VASCULOTROPIN; VIMENTIN; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; AQUEOUS HUMOR; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CELL VIABILITY; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CONCENTRATION PROCESS; CONTROLLED STUDY; FIBROBLAST; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; MESENCHYMAL STROMA CELL; MOUSE; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; RETINA DEGENERATION; RETINITIS PIGMENTOSA; XENOGRAFT; ANIMAL; CELL PROLIFERATION; CYTOLOGY; METABOLISM; PATHOLOGY; RETINAL DEGENERATION; STEM CELL TRANSPLANTATION;

IPS; MUS;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; GRAFT SURVIVAL; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STROMAL CELLS; MICE; NEURAL STEM CELLS; NEUROPROTECTIVE AGENTS; PHOTORECEPTOR CELLS, VERTEBRATE; RETINAL DEGENERATION; RETINAL PIGMENT EPITHELIUM; STEM CELL TRANSPLANTATION;

EID: 84928553428     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1960     Document Type: Article

References (83)

1. Strauss O,. The retinal pigment epithelium in visual function. Physiol Rev 2005; 85: 845-881.
2. Li LX, Turner JE,. Inherited retinal dystrophy in the RCS rat: Prevention of photoreceptor degeneration by pigment epithelial cell transplantation. Exp Eye Res 1988; 47: 911-917.
3. Bowne SJ, Humphries MM, Sullivan LS, et al. A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement. Eur J Hum Genet 2011; 19: 1074-1081.
4. Gal A, Li Y, Thompson DA, et al. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet 2000; 26: 270-271.
5. Tombran-Tink J, Chader GG, Johnson LV,. PEDF: A pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991; 53: 411-414.
6. Kanemura H, Go MJ, Nishishita N, et al. Pigment epithelium-derived factor secreted from retinal pigment epithelium facilitates apoptotic cell death of iPSC. Sci Rep 2013; 3: 2334.
7. Taniwaki T, Hirashima N, Becerra SP, et al. Pigment epithelium-derived factor protects cultured cerebellar granule cells against glutamate-induced neurotoxicity. J Neurochem 1997; 68: 26-32.
8. Cao W, Tombran-Tink J, Chen W, et al. Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J Neurosci Res 1999; 57: 789-800.
9. Cao W, Tombran-Tink J, Elias R, et al. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2001; 42: 1646-1652.
10. Takita H, Yoneya S, Gehlbach PL, et al. Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2003; 44: 4497-4504.
11. Cayouette M, Smith SB, Becerra SP, et al. Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations. Neurobiol Dis 1999; 6: 523-532.
12. Fischer AJ, Bongini R,. Turning Müller glia into neural progenitors in the retina. Mol Neurobiol 2010; 42: 199-209.
13. Coles BL, Angenieux B, Inoue T, et al. Facile isolation and the characterization of human retinal stem cells. Proc Natl Acad Sci USA 2004; 101: 15772-15777.
14. Kicic A, Shen WY, Wilson AS, et al. Differentiation of marrow stromal cells into photoreceptors in the rat eye. J Neurosci 2003; 23: 7742-7749.
15. Arnhold S, Absenger Y, Klein H, et al. Transplantation of bone marrow-derived mesenchymal stem cells rescue photoreceptor cells in the dystrophic retina of the rhodopsin knockout mouse. Graefes Arch Clin Exp Ophthalmol 2007; 245: 414-422.
16. Xiong N, Zhang Z, Huang J, et al. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease. Gene Ther 2011; 18: 394-402.
17. Pressmar S, Ader M, Richard G, et al. The fate of heterotopically grafted neural precursor cells in the normal and dystrophic adult mouse retina. Invest Ophthalmol Vis Sci 2001; 42: 3311-3319.
18. McGill TJ, Cottam B, Lu B, et al. Transplantation of human central nervous system stem cells-Neuroprotection in retinal degeneration. Eur J Neurosci 2012; 35: 468-477.
19. Pluchino S, Quattrini A, Brambilla E, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003; 422: 688-694.
20. Barhoum R, Martinez-Navarrete G, Corrochano S, et al. Functional and structural modifications during retinal degeneration in the rd10 mouse. Neuroscience 2008; 155: 698-713.
21. Bowes C, Li T, Danciger M, et al. Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature 1990; 347: 677-680.
22. Kamao H, Mandai M, Okamoto S, et al. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Reports 2014; 2: 205-218.
23. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
24. Halfon S, Abramov N, Grinblat B, et al. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev 2011; 20: 53-66.
25. Covas DT, Panepucci RA, Fontes AM, et al. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp Hematol 2008; 36: 642-654.
26. Lund RD, Wang S, Lu B, et al. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 2007; 25: 602-611.
27. Wagner W, Horn P, Castoldi M, et al. Replicative senescence of mesenchymal stem cells: A continuous and organized process. PLoS One 2008; 3: e2213.
28. Gamm DM, Melvan JN, Shearer RL, et al. A novel serum-free method for culturing human prenatal retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2008; 49: 788-799.
29. Gamm DM, Wang S, Lu B, et al. Protection of visual functions by human neural progenitors in a rat model of retinal disease. PLoS One 2007; 2: e338.
30. Tombran-Tink J, Shivaram SM, Chader GJ, et al. Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci 1995; 15: 4992-5003.
31. Ishida K, Yoshimura N, Yoshida M, et al. Expression of neurotrophic factors in cultured human retinal pigment epithelial cells. Curr Eye Res 1997; 16: 96-101.
32. Martino G, Pluchino S,. The therapeutic potential of neural stem cells. Nat Rev Neurosci 2006; 7: 395-406.
33. Klassen HJ, Imfeld KL, Kirov II, et al. Expression of cytokines by multipotent neural progenitor cells. Cytokine 2003; 22: 101-106.
34. Zhang Y, Wang W,. Effects of bone marrow mesenchymal stem cell transplantation on light-damaged retina. Invest Ophthalmol Vis Sci 2010; 51: 3742-3748.
35. Wang J, Liao L, Tan J,. Mesenchymal-stem-cell-based experimental and clinical trials: Current status and open questions. Expert Opin Biol Ther 2011; 11: 893-909.
36. Horwitz EM, Dominici M,. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy 2008; 10: 771-774.
37. Suzumura A, Sawada M, Yamamoto H, et al. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 1993; 151: 2150-2158.
38. Jones LL, Kreutzberg GW, Raivich G,. Transforming growth factor beta's 1, 2 and 3 inhibit proliferation of ramified microglia on an astrocyte monolayer. Brain Res 1998; 795: 301-306.
39. Li P, Tessler A, Han SS, et al. Fate of immortalized human neuronal progenitor cells transplanted in rat spinal cord. Arch Neurol 2005; 62: 223-229.
40. Mandai M, Homma K, Okamoto S, et al. Adequate time window and environmental factors supporting retinal graft cell survival in rd mice. Cell Med 2012; 4: 45-54.
41. Li Y, Tsai YT, Hsu CW, et al. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Mol Med 2012; 18: 1312-1319.
42. Carr AJ, Vugler AA, Hikita ST, et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 2009; 4: e8152.
43. He S, Wang HM, Ogden TE, et al. Transplantation of cultured human retinal pigment epithelium into rabbit subretina. Graefes Arch Clin Exp Ophthalmol 1993; 231: 737-742.
44. Berglin L, Gouras P, Sheng Y, et al. Tolerance of human fetal retinal pigment epithelium xenografts in monkey retina. Graefes Arch Clin Exp Ophthalmol 1997; 235: 103-110.
45. Warfvinge K, Schwartz PH, Kiilgaard JF, et al. Xenotransplantation of human neural progenitor cells to the subretinal space of nonimmunosuppressed pigs. J Transplant 2011; 2011: 948740.
46. Sugita S, Futagami Y, Smith SB, et al. Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta. Exp Eye Res 2006; 83: 1459-1471.
47. Vega JL, Saban D, Carrier Y, et al. Retinal pigment epithelial cells induce foxp3(+) regulatory T cells via membrane-bound TGF-beta. Ocul Immunol Inflamm 2010; 18: 459-469.
48. Sugita S, Horie S, Nakamura O, et al. Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells. J Immunol 2008; 181: 7525-7536.
49. Paglinawan R, Malipiero U, Schlapbach R, et al. TGFbeta directs gene expression of activated microglia to an anti-inflammatory phenotype strongly focusing on chemokine genes and cell migratory genes. Glia 2003; 44: 219-231.
50. Matsuda S, Koyasu S,. Mechanisms of action of cyclosporine. Immunopharmacology 2000; 47: 119-125.
51. Shii D, Nakagawa S, Shinomiya K, et al. Cyclosporin A eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction. Curr Eye Res 2009; 34: 426-437.
52. Frasson M, Sahel JA, Fabre M, et al. Retinitis pigmentosa: Rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat Med 1999; 5: 1183-1187.
53. Delyfer MN, Forster V, Neveux N, et al. Evidence for glutamate-mediated excitotoxic mechanisms during photoreceptor degeneration in the rd1 mouse retina. Mol Vis 2005; 11: 688-696.
54. Ahuja-Jensen P, Johnsen-Soriano S, Ahuja S, et al. Low glutathione peroxidase in rd1 mouse retina increases oxidative stress and proteases. Neuroreport 2007; 18: 797-801.
55. Wright AF, Chakarova CF, Abd El-Aziz MM, et al. Photoreceptor degeneration: Genetic and mechanistic dissection of a complex trait. Nat Rev Genet 2010; 11: 273-284.
56. Murakami Y, Ikeda Y, Yonemitsu Y, et al. Inhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism of the neuroprotective activity of pigment epithelium-derived factor in a rat model of retinal degeneration. Am J Pathol 2008; 173: 1326-1338.
57. Bilak MM, Corse AM, Bilak SR, et al. Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J Neuropathol Exp Neurol 1999; 58: 719-728.
58. Houenou LJ, D'Costa AP, Li L, et al. Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons. J Comp Neurol 1999; 412: 506-514.
59. Bai YJ, Huang LZ, Xu XL, et al. Polyethylene glycol-modified pigment epithelial-derived factor: New prospects for treatment of retinal neovascularization. J Pharmacol Exp Ther 2012; 342: 131-139.
60. Acharya NR, Sittivarakul W, Qian Y, et al. Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema. Retina 2011; 31: 1871-1876.
61. Hanhart J, Tiosano L, Averbukh E, et al. Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema. Eye (Lond) 2014; 28: 646-653.
62. Wu Z, Sadda SR,. Effects on the contralateral eye after intravitreal bevacizumab and ranibizumab injections: A case report. Ann Acad Med Singapore 2008; 37: 591-593.
63. Nomoto H, Shiraga F, Kuno N, et al. Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits. Invest Ophthalmol Vis Sci 2009; 50: 4807-4813.
64. Zou L, Lai H, Zhou Q, et al. Lasting controversy on ranibizumab and bevacizumab. Theranostics 2011; 1: 395-402.
65. Tombran-Tink J, Barnstable CJ,. PEDF: A multifaceted neurotrophic factor. Nat Rev Neurosci 2003; 4: 628-636.
66. Azzouz M, Ralph GS, Storkebaum E, et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004; 429: 413-417.
67. Sun Y, Jin K, Xie L, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003; 111: 1843-1851.
68. Tovar YRLB, Tapia R,. VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3-K pathway and inhibition of p38MAPK. J Neurochem 2010; 115: 1090-1101.
69. Semkova I, Haberlein C, Krieglstein J,. Ciliary neurotrophic factor protects hippocampal neurons from excitotoxic damage. Neurochem Int 1999; 35: 1-10.
70. Zhu L, Du F, Yang L, et al. Nerve growth factor protects the cortical neurons from chemical hypoxia-induced injury. Neurochem Res 2008; 33: 784-789.
71. Lambiase A, Aloe L,. Nerve growth factor delays retinal degeneration in C3H mice. Graefes Arch Clin Exp Ophthalmol 1996; 234 (suppl 1): S96-S100.
72. Carnicero E, Knipper M, Tan J, et al. Herpes simplex virus type 1-mediated transfer of neurotrophin-3 stimulates survival of chicken auditory sensory neurons. Neurosci Lett 2002; 321: 149-152.
73. Shen W, Zhu L, Lee SR, et al. Involvement of NT3 and P75(NTR) in photoreceptor degeneration following selective Muller cell ablation. J Neuroinflammation 2013; 10: 137.
74. Akerud P, Canals JM, Snyder EY, et al. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J Neurosci 2001; 21: 8108-8118.
75. Martinez-Serrano A, Lundberg C, Horellou P, et al. CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: Complete rescue of axotomized cholinergic neurons after transplantation into the septum. J Neurosci 1995; 15: 5668-5680.
76. Jung G, Sun J, Petrowitz B, et al. Genetically modified neural stem cells for a local and sustained delivery of neuroprotective factors to the dystrophic mouse retina. Stem Cells Transl Med 2013; 2: 1001-1010.
77. Maeda T, Lee MJ, Palczewska G, et al. Retinal pigmented epithelial cells obtained from human induced pluripotent stem cells possess functional visual cycle enzymes in vitro and in vivo. J Biol Chem 2013; 288: 34484-34493.
78. Hashimoto Y, Kase S, Saito W, et al. Abnormalities of fundus autofluorescence in pigmented paravenous chorioretinal atrophy. Open Ophthalmol J 2012; 6: 125-128.
79. Mitamura Y, Mitamura-Aizawa S, Nagasawa T, et al. Diagnostic imaging in patients with retinitis pigmentosa. J Med Invest 2012; 59: 1-11.
80. Bhutto IA, McLeod DS, Hasegawa T, et al. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res 2006; 82: 99-110.
81. Amaral J, Becerra SP,. Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization. Invest Ophthalmol Vis Sci 2010; 51: 1318-1326.
82. Mori K, Duh E, Gehlbach P, et al. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol 2001; 188: 253-263.
83. Rosenfeld PJ, Shapiro H, Tuomi L, et al. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology 2011; 118: 523-530.